In this rubric we present you scientific news from the world of chitin and chitosan. Monthly you can find recent publications. We hope to arouse your interest in this biopolymer or to help you out. If you have any comments or if you do chitin or chitosan research and you want to publish your article on this page,
Have fun browsing on our pages!
In March and April 262 publications were released about Chitosan, which mainly focused on animal and human studies, nanoparticles and pharmaceutical preparations. The most successful nations in the field of chitosan research have been: China (83 articles), India (31) and USA (22).
At the beginning of year 2013 numerous articles about chitosan and chitosan derivatives were published. All in all 286 publications were released in January and February by leading scientists from China (86 articles), USA (25) and India (25). The main research field addresses chitosan in animal and human studies, nanoparticles and pharmaceutical preparations.
In April researchers and developer could be delighted by 147 publications about chitosan and chitosan derivatives. Again, most articles were published in China (40 articles), followed by India (13) and the US (11).
The antimicrobial effect of chitosan is well known and has already been used in dentistry to prevent caries as well as in the food packaging industry as a preservative agent.
chitosan, nanoparticles, wound healing, Escherichia coli, Staphylococcus saprophyticus
Overall 131 articles about chitosan and chitosan derivatives were published in March 2012.
As in the previous month, China is the country with the most publications with overall 35 articles, followed by the USA (14 articles), India (9 articles) and Taiwan (8 articles).
In February 2012 the Technical University (TU) of Vienna filed a patent for a new production method of the popular pharmaceutical raw material N-acetylneuraminic acid (NeuNAc). Molds were used as “chemical factories” and were combined with the biological raw material chitin to obtain the desired final product.